NOTE 11 - STOCKHOLDERS' EQUITY

12 Months Ended

Dec. 31, 2015

Stockholders' Equity Note [Abstract]

Stockholders' Equity Note Disclosure [Text Block]

NOTE 11 – STOCKHOLDERS' EQUITY

Sales of Common Stock 

During 2015, the Company issued the following shares of restricted stock:

Purpose	Number of Shares		Total Cost		Average Cost/Share
Acquisition of operating assets		4,750,000	$	977,500	$	0.21
Employee performance bonus		1,000,000	$	190,000	$	0.19
Various services		450,000	$	136,500	$	0.30
Totals		6,200,000	$	1,304,000	$	0.21

During 2014, the Company issued the following shares of restricted stock:

Purpose	Number of Shares		Total Cost		Average Cost/Share
Acquisition of operating assets		7,519,445	$	3,224,750	$	0.57
Financing charges		350,000	$	140,000	$	0.40
Various services		451,055	$	120,317	$	0.27
Warrant exercise		1,874,584	$	1,124,750	$	0.60
Totals		10,195,084	$	4,609,817	$	0.45

Warrants

The Company has outstanding the following warrants to purchase the Company’s common stock as of December 31,

	2015		2014
Financing and stock subscriptions		8,579,030		8,579,030
Note Extensions		2,843,064		2,843,064
Management		7,007,693		4,500,000
Debt conversion		1,666,668		1,666,667
Total Reserved		20,096,454		17,588,761

A summary of warrant issuances based on common stock equivalents is as follows:

	Number of Shares			Exercise Price		Weighted Average Exercise Price
Balance at December 31, 2012		12,026,678		$	0.36 – 0.60	$	0.51
Warrants exercised		(1,700,000	)
Warrants expired		-
Warrants issued to management		2,500,000		$	0.10
Warrants issued for debt conversion		1,666,667		$	0.36
Warrants issued with stock subscription		666,667		$	0.36
Balance at December 31, 2013		15,160,012		$	0.10 – 0.36	$	0.47
Warrants exercised		(1,874,584	)		0.60
Warrants expired		-
Warrants issued to management		2,000,000		$	0.10
Warrants issued for financing		2,303,333		$	0.60
Balance at December 31, 2014		17,588,761		$	0.10 – 0.60	$	0.55
Warrants exercised		-
Warrants expired		-
Warrants issued to management		50,000		$	0.10
Warrants issued to management		2,507,693		$	0.01
Balance at December 31, 2015		20,096,454		$	0.01 – 0.10	$	0.48

All outstanding warrants are currently exercisable.  A summary of outstanding common stock warrants at December 31, 2015 follows:

Number of Common Stock Warrants		Expiration Date	Remaining Contractual Life (Years)		Exercise price
	3,400,000	10/25/2016		0.8	$	0.60
	446,042	10/25/2016		0.8	$	0.60
	281	10/25/2016		0.8	$	0.60
	1,333,333	12/26/2016		1.0	$	0.36
	2,000,000	5/1/2017		1.3	$	0.10
	629,371	10/25/2017		1.8	$	0.36
	2,059,734	12/31/2017		2.0	$	0.36
	583,333	12/31/2017		2.0	$	0.36
	50,000	12/31/2017		2.0	$	0.10
	2,500,000	7/1/2018		2.5	$	0.10
	1,666,667	12/31/2018		3.0	$	0.36
	666,667	12/31/2018		3.0	$	0.36
	250,000	10/28/2019		3.8	$	0.60
	2,053,333	12/22/2019		4.0	$	0.60
	1,153,847	10/8/2020		4.8	$	0.01
	1,153,846	10/8/2020		4.8	$	0.01
	50,000	10/8/2020		4.8	$	0.01
	50,000	10/8/2020		4.8	$	0.01
	50,000	10/8/2020		4.8	$	0.01
	20,096,454

On December 31, 2015, the Company changed the exercise price on certain warrants to purchase the Company’s common stock from $1.00 per share to $0.36 per share. Since the calculated Black Scholes value of these warrants decreased, no change was recorded.